$LFLY
Leafly Holdings, Inc. /DE Stock $lfly

$lfly Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000121390021019193 Filed on March 31, 2021

Income Statement

Concept	2020 Q4	2019 Q4	2019 Q2
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$148.3K	$170.0K
YoY Change	-12.75%
Operating Profit
YoY Change
Interest Expense	$34.42K	$300.0K
YoY Change	-88.53%
% of Operating Profit
Other Income/Expense, Net	-$1.975M
YoY Change
Pretax Income	-$2.089M	$130.0K
YoY Change	-1706.97%
Income Tax	-$23.92K	$30.00K
% Of Pretax Income		23.08%
Net Earnings	-$2.065M	$100.0K	-$339.00
YoY Change	-2165.14%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$125.8K	$0.12
COMMON SHARES
Basic Shares Outstanding	16.37M shares	16.57M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q4	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$130.9M	$130.7M
YoY Change	0.14%
Cash & Equivalents	$171.5K	$362.6K
Short-Term Investments	$130.7M	$130.3M
Other Short-Term Assets	$99.74K	$200.0K
YoY Change	-50.13%
Inventory
Prepaid Expenses	$99.74K	$176.9K
Receivables
Other Receivables
Total Short-Term Assets	$271.3K	$539.4K
YoY Change	-49.71%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$130.7M	$130.3M
YoY Change	0.29%
Other Assets
YoY Change
Total Long-Term Assets	$130.7M	$130.3M
YoY Change	0.28%
TOTAL ASSETS
Total Short-Term Assets	$271.3K	$539.4K
Total Long-Term Assets	$130.7M	$130.3M
Total Assets	$131.0M	$130.9M
YoY Change	0.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$100.0K
YoY Change
Accrued Expenses		$100.0K
YoY Change
Deferred Revenue	$1.585M
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$170.5K	$170.6K
YoY Change	-0.07%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.950M
YoY Change
Total Long-Term Liabilities	$3.950M	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$170.5K	$170.6K
Total Long-Term Liabilities	$3.950M	$0.00
Total Liabilities	$4.121M	$170.7K
YoY Change	2314.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.714M	$101.5K
YoY Change	-3759.26%
Common Stock	$337.00	$382.00
YoY Change	-11.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.069M	-$1.492M
YoY Change
Total Liabilities & Shareholders Equity	$131.0M	$130.9M
YoY Change	0.08%

Cashflow Statement

Concept	2020 Q4	2019 Q4	2019 Q2
OPERATING ACTIVITIES
Net Income	-$2.065M	$100.0K	-$339.00
YoY Change	-2165.14%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$71.35K	-$220.0K
YoY Change	-67.57%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$130.0M
YoY Change	-100.0%
Cash From Investing Activities	$0.00	-$130.0M
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		130.6M
YoY Change
NET CHANGE
Cash From Operating Activities	-71.35K	-220.0K
Cash From Investing Activities	0.000	-130.0M
Cash From Financing Activities		130.6M
Net Change In Cash	-71.35K	350.0K
YoY Change	-120.39%
FREE CASH FLOW
Cash From Operating Activities	-$71.35K	-$220.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Document Type DocumentType	10-K
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3844815	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3844815	shares
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001785592
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Entity File Number EntityFileNumber	001-39119
CY2020	dei	Entity Registrant Name EntityRegistrantName	MERIDA MERGER CORP. I
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	true
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2020	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2020	dei	Entity Shell Company EntityShellCompany	true
CY2020Q2	dei	Entity Public Float EntityPublicFloat	127285194	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16371940	shares
CY2020Q4	us-gaap	Cash Cash	171540	USD
CY2019Q4	us-gaap	Cash Cash	362570	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	99735	USD
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	176869	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	271275	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	539439	USD
CY2020Q4	us-gaap	Marketable Securities MarketableSecurities	130681047	USD
CY2019Q4	us-gaap	Marketable Securities MarketableSecurities	130311535	USD
CY2020Q4	us-gaap	Assets Assets	130952322	USD
CY2019Q4	us-gaap	Assets Assets	130850974	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	147830	USD
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	126891	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	5883	USD
CY2019Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	26934	USD
CY2020Q4	MCMJ	Advances From Related Party AdvancesFromRelatedParty	16458	USD
CY2019Q4	MCMJ	Advances From Related Party AdvancesFromRelatedParty	16458	USD
CY2020Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	339	USD
CY2019Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	339	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	170510	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	170622	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	432	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	48	USD
CY2020Q4	us-gaap	Liabilities Liabilities	170942	USD
CY2019Q4	us-gaap	Liabilities Liabilities	170670	USD
CY2020Q4	MCMJ	Temporary Equity Common Stock Possible To Redemption Shares TemporaryEquityCommonStockPossibleToRedemptionShares	12527125	shares
CY2019Q4	MCMJ	Temporary Equity Common Stock Possible To Redemption Shares TemporaryEquityCommonStockPossibleToRedemptionShares	12550477	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	125781370	USD
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	125680303	USD
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2020	us-gaap	Direct Operating Costs DirectOperatingCosts	661218	USD
	us-gaap	Direct Operating Costs DirectOperatingCosts	167531	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-661218	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-167531	USD
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3821463	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3821463	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	384	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	382	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4797048	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4898117	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	202578	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	101502	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5000010	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	5000001	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	130952322	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	130850974	USD
CY2020	us-gaap	Interest And Other Income InterestAndOtherIncome	787350	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	295788	USD
CY2020	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	2056	USD
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	227	USD
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	789406	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	296015	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	128188	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	128484	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27112	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26982	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	101076	USD
	us-gaap	Net Income Loss NetIncomeLoss	101502	USD
CY2020	MCMJ	Basic And Diluted Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption	12547286	shares
	MCMJ	Basic And Diluted Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption	12446534	shares
CY2020	MCMJ	Basic And Diluted Net Income Per Share Common Stock Subject To Possible Redemption BasicAndDilutedNetIncomePerShareCommonStockSubjectToPossibleRedemption	0.05
	MCMJ	Basic And Diluted Net Income Per Share Common Stock Subject To Possible Redemption BasicAndDilutedNetIncomePerShareCommonStockSubjectToPossibleRedemption	0.01
CY2020	MCMJ	Basic And Diluted Weighted Average Shares Outstanding Nonredeemable Common Stock BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableCommonStock	3824645	shares
	MCMJ	Basic And Diluted Weighted Average Shares Outstanding Nonredeemable Common Stock BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableCommonStock	3305465	shares
CY2020	MCMJ	Basic And Diluted Net Loss Per Share Nonredeemable Common Stock BasicAndDilutedNetLossPerShareNonredeemableCommonStock	-0.12
	MCMJ	Basic And Diluted Net Loss Per Share Nonredeemable Common Stock BasicAndDilutedNetLossPerShareNonredeemableCommonStock	-0.02
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity		USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	910	USD
CY2020	MCMJ	Sale Of Units Net Of Underwriting Discounts And Offering Expenses SaleOfUnitsNetOfUnderwritingDiscountsAndOfferingExpenses	13001552	shares
	MCMJ	Sale Of13001552 Units Net Of Underwriting Discounts And Offering Expenses SaleOf13001552UnitsNetOfUnderwritingDiscountsAndOfferingExpenses	126602581	USD
CY2020	MCMJ	Sale Of Private Warrants SaleOfPrivateWarrants	3950311	shares
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3950311	USD
	MCMJ	Stock Issued During Period Value Common Stock Subject To Possible Redemption StockIssuedDuringPeriodValueCommonStockSubjectToPossibleRedemption	-125680303	USD
	MCMJ	Stock Issued During Period Forfeiture Of Founder Shares Value StockIssuedDuringPeriodForfeitureOfFounderSharesValue		USD
	us-gaap	Net Income Loss NetIncomeLoss	101502	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	5000001	USD
CY2020	MCMJ	Stock Issued During Period Value Common Stock Subject To Possible Redemption StockIssuedDuringPeriodValueCommonStockSubjectToPossibleRedemption	-101067	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	101076	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5000010	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	101076	USD
	us-gaap	Net Income Loss NetIncomeLoss	101502	USD
CY2020	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	787350	USD
	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	295788	USD
CY2020	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	2056	USD
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	227	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	384	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	48	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-77134	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	176859	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	20939	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	126891	USD
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-21051	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	26934	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-610924	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-217499	USD
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	130015520	USD
CY2020	MCMJ	Cash Withdrawn From Trust Account For Franchise And Income Tax Payments CashWithdrawnFromTrustAccountForFranchiseAndIncomeTaxPayments	419894	USD
	MCMJ	Cash Withdrawn From Trust Account For Franchise And Income Tax Payments CashWithdrawnFromTrustAccountForFranchiseAndIncomeTaxPayments		USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	419894	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-130015520	USD
CY2020	MCMJ	Proceeds From Sale Of Units Net Of Underwriting Discounts Paid ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid		USD
	MCMJ	Proceeds From Sale Of Units Net Of Underwriting Discounts Paid ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid	127415209	USD
CY2020	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3950311	USD
CY2020	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt		USD
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	203958	USD
CY2020	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt		USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	187500	USD
CY2020	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	100569	USD
CY2020	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		USD
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-100230	USD
CY2020	MCMJ	Payment Of Offering Costs PaymentOfOfferingCosts		USD
	MCMJ	Payment Of Offering Costs PaymentOfOfferingCosts	-786728	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	130595589	USD
CY2020	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-191030	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	362570	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	362570	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	171540	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	47779	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		USD
CY2020	MCMJ	Initial Classification Of Common Stock Subject To Possible Redemption InitialClassificationOfCommonStockSubjectToPossibleRedemption		USD
	MCMJ	Initial Classification Of Common Stock Subject To Possible Redemption InitialClassificationOfCommonStockSubjectToPossibleRedemption	125578180	USD
CY2020	MCMJ	Change In Value Of Common Stock Subject To Possible Redemption ChangeInValueOfCommonStockSubjectToPossibleRedemption	101067	USD
	MCMJ	Change In Value Of Common Stock Subject To Possible Redemption ChangeInValueOfCommonStockSubjectToPossibleRedemption	102123	USD
CY2020	MCMJ	Issuance Of Representative Shares IssuanceOfRepresentativeShares		USD
	MCMJ	Issuance Of Representative Shares IssuanceOfRepresentativeShares	910	USD
CY2020	MCMJ	Offering Cost Paid Directly By Stockholder In Consideration For Issuance Of Common Stock OfferingCostPaidDirectlyByStockholderInConsiderationForIssuanceOfCommonStock		USD
	MCMJ	Offering Cost Paid Directly By Stockholder In Consideration For Issuance Of Common Stock OfferingCostPaidDirectlyByStockholderInConsiderationForIssuanceOfCommonStock	25000	USD
CY2020	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"><span style="font-weight:bold;">NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Merida Merger Corp. I (the “Company”) was incorporated in Delaware on June 20, 2019. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"/></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company intends to focus its search on companies in the cannabis industry. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">As of December 31, 2020, the Company had not commenced any operations. All activity through December 31, 2020 relates to the Company’s formation, the IPO (“IPO”), which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the IPO.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">The registration statements for the Company’s IPO were declared effective on November 4, 2019. On November 7, 2019, the Company consummated the IPO of 12,000,000 units (the “Units” and, with respect to the shares of common stock included in the Units sold, the “Public Shares”), generating gross proceeds of $120,000,000, which is described in Note 3.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Simultaneously with the closing of the IPO, the Company consummated the sale of 3,750,000 warrants (the “Private Warrants”) at a price of $1.00 per Private Warrant in a private placement to Merida Holdings, LLC and EarlyBirdCapital, Inc. (“EarlyBirdCapital”), generating gross proceeds of $3,750,000, which is described in Note 4.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Following the closing of the IPO on November 7, 2019, an amount of $120,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Warrants was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the Trust Account to the Company’s stockholders, as described below.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">On November 12, 2019, the underwriters notified the Company of their intention to partially exercise their over-allotment option on November 13, 2019. As such, on November 13, 2019 the Company consummated the sale of an additional 1,001,552 Units, at $10.00 per Unit, and the sale of an additional 200,311 Private Warrants, at $1.00 per Private Warrant, generating total gross proceeds of $10,215,831. A total of $10,015,520 of the net proceeds was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $130,015,520.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Transaction costs amounted to $3,412,939 consisting of $2,600,311 of underwriting fees and $812,628 of other offering costs.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination in connection with a stockholder meeting called to approve the Business Combination. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations and up to $250,000 per 12-month period for working capital needs). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. The Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules. The Company’s Sponsor and EarlyBirdCapital have agreed to vote their Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the IPO in favor of approving a Business Combination and not to convert any shares in connection with a stockholder vote to approve a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or don’t vote at all.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">The Sponsor has agreed (a) to waive its redemption rights with respect to the Founder Shares and any Public Shares held by it in connection with the completion of a Business Combination, (b) to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to consummate a Business Combination, and (c) not to propose an amendment to the Amended and Restated Certificate of Incorporation that would affect a public stockholders’ ability to convert their shares in connection with a Business Combination or affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">The Company will have until November 7, 2021 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company, divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">In order to protect the amounts held in the Trust Account, Merida Manager III LLC, the general partner of the Sponsor, has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.00 per Public Share, except as to any claims by a third party who executed a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, Merida Manager III LLC will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that Merida Manager III LLC will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"><span style="font-weight:bold;"><i>Risks and Uncertainties</i></span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or closing of a business combination, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3412939	USD
CY2020Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	812628	USD
CY2020	MCMJ	Aggregate Fair Market Value Percentage AggregateFairMarketValuePercentage	0.80	pure
CY2020	MCMJ	Business Combination Owns Or Acquires Percentage BusinessCombinationOwnsOrAcquiresPercentage	0.50	pure
CY2020	MCMJ	Withdrawal Amount Of Working Capital Purposes On Annual Basis WithdrawalAmountOfWorkingCapitalPurposesOnAnnualBasis	250000	USD
CY2020	MCMJ	Public Share Percentage PublicSharePercentage	1	pure
CY2020	MCMJ	Business Combination Period BusinessCombinationPeriod	2021-11-07
CY2020Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.00
CY2020Q4	MCMJ	Minimum Amount Of Net Tangible Assets To Complete Business Combination MinimumAmountOfNetTangibleAssetsToCompleteBusinessCombination	5000001	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"><span style="font-weight:bold;"><i>Use of Estimates</i></span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">The preparation of the financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p>
CY2020	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	419894	USD
	MCMJ	Net Income Allocable To Common Stock Subject To Possible Redemption NetIncomeAllocableToCommonStockSubjectToPossibleRedemption	-175485	USD
CY2020	MCMJ	Nonredeemable Net Loss NonredeemableNetLoss	-474339	USD
	us-gaap	Net Income Loss NetIncomeLoss	101502	USD
CY2020	MCMJ	Net Income Allocable To Common Stock Subject To Possible Redemption NetIncomeAllocableToCommonStockSubjectToPossibleRedemption	-575415	USD
	MCMJ	Nonredeemable Net Loss NonredeemableNetLoss	-73983	USD
CY2020Q4	MCMJ	Class Of Warrant To Purchase Shares Of Common Stock ClassOfWarrantToPurchaseSharesOfCommonStock	10451087	shares
CY2020	us-gaap	Interest And Dividend Income Securities Other InterestAndDividendIncomeSecuritiesOther	758612	USD
	us-gaap	Interest And Dividend Income Securities Other InterestAndDividendIncomeSecuritiesOther	285524	USD
CY2020	MCMJ	Unrealized Gain Loss On Marketable Securities Held In Trust Account UnrealizedGainLossOnMarketableSecuritiesHeldInTrustAccount	1981	USD
	MCMJ	Unrealized Gain Loss On Marketable Securities Held In Trust Account UnrealizedGainLossOnMarketableSecuritiesHeldInTrustAccount	219	USD
CY2020	MCMJ	Less Interest Available To Be Withdrawn For Payment Of Taxes LessInterestAvailableToBeWithdrawnForPaymentOfTaxes	-185178	USD
	MCMJ	Less Interest Available To Be Withdrawn For Payment Of Taxes LessInterestAvailableToBeWithdrawnForPaymentOfTaxes	-110258	USD
CY2020	MCMJ	Less Interest Available To Be Withdrawn For Working Capital LessInterestAvailableToBeWithdrawnForWorkingCapital		USD
CY2020	MCMJ	Net Income Attributable NetIncomeAttributable	575415	USD
	MCMJ	Net Income Attributable NetIncomeAttributable	175485	USD
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	12547286	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	12446534	shares
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.05
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.01
CY2020	us-gaap	Net Income Loss NetIncomeLoss	101076	USD
CY2020	MCMJ	Basic And Diluted Weighted Average Shares Outstanding Nonredeemable Common Stock BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableCommonStock	3824645	shares
	MCMJ	Basic And Diluted Weighted Average Shares Outstanding Nonredeemable Common Stock BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableCommonStock	3305465	shares
CY2020	MCMJ	Basic And Diluted Net Loss Per Share Nonredeemable Common Stock BasicAndDilutedNetLossPerShareNonredeemableCommonStock	-0.12
	MCMJ	Basic And Diluted Net Loss Per Share Nonredeemable Common Stock BasicAndDilutedNetLossPerShareNonredeemableCommonStock	-0.02
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"><span style="font-weight:bold;"><i>Concentration of Credit Risk</i></span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p>
CY2020Q4	MCMJ	Federal Depository Insurance Coverage FederalDepositoryInsuranceCoverage	250000	USD
CY2019Q3	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	2875000	shares
CY2019Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000	USD
CY2019Q4	MCMJ	Stock Dividend Description StockDividendDescription	the Company effected a stock dividend of 0.2 shares for each share outstanding,
CY2020	us-gaap	Business Combination Control Obtained Description BusinessCombinationControlObtainedDescription	The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until, with respect to 50% of the Founder Shares, the earlier of one year after the consummation of a Business Combination and the date on which the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing after a Business Combination and, with respect to the remaining 50% of the Founder Shares, until the one year after the consummation of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company completes a liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.
CY2019Q4	MCMJ	Office Space Utilities And Secretarial And Administrative Support OfficeSpaceUtilitiesAndSecretarialAndAdministrativeSupport	5000	USD
CY2020	us-gaap	Professional Fees ProfessionalFees	50000	USD
	us-gaap	Professional Fees ProfessionalFees	20000	USD
CY2020Q4	us-gaap	Accrued Liabilities Fair Value Disclosure AccruedLiabilitiesFairValueDisclosure	5000	USD
CY2019Q4	us-gaap	Accrued Liabilities Fair Value Disclosure AccruedLiabilitiesFairValueDisclosure	20000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	162500	USD
CY2019Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	162500	USD
CY2020	MCMJ	Cover Expenses CoverExpenses	41458	USD
CY2019Q4	MCMJ	Outstanding Promissory Notes OutstandingPromissoryNotes	16458	USD
CY2020Q4	MCMJ	Outstanding Promissory Notes OutstandingPromissoryNotes	16458	USD
CY2019Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	100569	USD
CY2020	us-gaap	Debt Instrument Description DebtInstrumentDescription	The Promissory Note was non-interest bearing and payable on the earlier of (i) September 30, 2020, (ii) the consummation of the IPO or (iii) the date on which the Company determined not to proceed with the IPO. As of December 31, 2019, the Company repaid $100,230 of amounts owed under the Promissory Note and $339 remained outstanding under the Promissory Note at December 31, 2020 and 2019
CY2020Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	1500000	USD
CY2020Q4	us-gaap	Business Acquisition Share Price BusinessAcquisitionSharePrice	1.00
CY2020Q4	MCMJ	Gross Proceeds Percentage GrossProceedsPercentage	0.035	pure
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3821463	shares
CY2020Q4	MCMJ	Common Stock Subject To Possible Redemption Share CommonStockSubjectToPossibleRedemptionShare	12527125	shares
CY2019Q4	MCMJ	Common Stock Subject To Possible Redemption Share CommonStockSubjectToPossibleRedemptionShare	12550477	shares
CY2020	us-gaap	Class Of Warrant Or Right Expense Or Revenue Recognized ClassOfWarrantOrRightExpenseOrRevenueRecognized	Once the warrants become exercisable, the Company may redeem the Public Warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days’ prior written notice of redemption; ● if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period commencing after the warrants become exercisable and ending on the third business day prior to the notice of redemption to the warrant holders; and ● If, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants.
CY2020Q4	MCMJ	Busniess Combination Issued Price BusniessCombinationIssuedPrice	9.20
CY2020	MCMJ	Aggregate Gross Proceeds Percentage AggregateGrossProceedsPercentage	0.60	pure
CY2020Q4	MCMJ	Market Value Per Share MarketValuePerShare	9.20
CY2020	MCMJ	Market Value Percentage MarketValuePercentage	1.15	pure
CY2020Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	432	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	48	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	432	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	48	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	432	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	48	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	26728	USD
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	26934	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	384	USD
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	48	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		USD
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		USD
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		USD
CY2020	MCMJ	Change In Valuation Allowance ChangeInValuationAllowance		USD
	MCMJ	Change In Valuation Allowance ChangeInValuationAllowance		USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27112	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26982	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.000	pure
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.000	pure
CY2020	MCMJ	Meals And Entertainment MealsAndEntertainment	0.001	pure
	MCMJ	Meals And Entertainment MealsAndEntertainment	0.000	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.211	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.210	pure

Files In Submission

Name	View Source	Status
0001213900-21-019193-index-headers.html	Edgar Link	pending
0001213900-21-019193-index.html	Edgar Link	pending
0001213900-21-019193.txt	Edgar Link	pending
0001213900-21-019193-xbrl.zip	Edgar Link	pending
f10k2020ex31-1_meridamerger.htm	Edgar Link	pending
f10k2020ex32_meridamerger.htm	Edgar Link	pending
f10k2020ex4-5_meridamerger.htm	Edgar Link	pending
f10k2020_meridamergercorp1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mcmj-20201231.xml	Edgar Link	completed
mcmj-20201231.xsd	Edgar Link	pending
mcmj-20201231_cal.xml	Edgar Link	unprocessable
mcmj-20201231_def.xml	Edgar Link	unprocessable
mcmj-20201231_lab.xml	Edgar Link	unprocessable
mcmj-20201231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LFLY
Leafly Holdings, Inc. /DE Stock $lfly

2020 Q4 Form 10-K Financial Statement

#000121390021019193 Filed on March 31, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFLY Leafly Holdings, Inc. /DE Stock $lfly

2020 Q4 Form 10-K Financial Statement

#000121390021019193 Filed on March 31, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFLY
Leafly Holdings, Inc. /DE Stock $lfly